The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Clindaseptin 25 mg capsules for dogs

25 Milligrams per capsule Capsule

Chanelle Pharmaceuticals Manufacturing LimitedVPA10987/163/001

Main Information

Trade NameClindaseptin 25 mg capsules for dogs
Active SubstancesClindamycin (as clindamycin hydrochloride)
Strength25 Milligrams per capsule
Dosage FormCapsule
Licence HolderChanelle Pharmaceuticals Manufacturing Limited
Licence NumberVPA10987/163/001

Group Information

ATC CodeQJ01FF01 clindamycin
Therapeutic ClassAntibacterial


Licence Issued18/07/2014
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportPDF Version
« Back